Zhejiang Shengda Bio-pharm Co., Ltd. Class ASSE: 603079

Announcement on Convening the 2025 Q3 Performance Briefing

· Issued by Zhejiang Shengda Bio-pharm Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the 2025 Q3 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment